Join the 200th Anniversary Celebration

Correspondence

Acute HIV Infection among Patients Tested for Mononucleosis

N Engl J Med 1999; 340:969March 25, 1999

Article

To the Editor:

Acute infection with human immunodeficiency virus type 1 (HIV-1) is associated with a self-limited, mononucleosis-like illness in the majority of persons. Symptoms may include fever, pharyngitis, lymphadenopathy, rash, oral and genital ulcerations, orthostasis, and gastrointestinal problems. Although many patients seek medical attention during acute HIV-1 infection, the diagnosis is often missed.1 In the early symptomatic stage, the standard enzyme-linked immunosorbent assay (ELISA) is negative for HIV-1, but tests for plasma HIV-1 RNA or plasma p24 antigen are positive. We hypothesized that health care providers are likely to perform testing for heterophil antibodies to Epstein–Barr virus in patients with the acute retroviral syndrome.

To test this hypothesis, we retrospectively performed quantitative HIV-1 RNA testing on serum collected for routine Epstein–Barr virus heterophil-antibody testing from 563 patients. Approval was obtained from the institutional review board to perform anonymous testing of all the heterophil-negative specimens from patients over 18 years of age. Serum specimens collected during a 12-month period were stored at –70°C before pooled testing with use of the Amplicor HIV Monitor test (Roche Diagnostic Systems). Each pooled sample consisted of 25 μl from eight different serum specimens. When viral RNA was detected, the eight specimens were tested individually.

Eleven of the 563 specimens (2.0 percent) were positive for HIV-1 RNA (Table 1Table 1Results of Testing in 11 Specimens Positive for HIV-1 RNA.). At least four of these (0.7 percent of the total) represented acute HIV-1 infection, with extremely high plasma levels of viral RNA but negative results on ELISA for HIV-1 and HIV type 2 (HIV-2). An additional 3 of the 11 patients (Patients 5, 6, and 7 in Table 1) had very high viral loads and positive results on ELISA for HIV-1 and HIV-2 and on assays for p24 antigen. These cases may represent acute HIV-1 retroviral syndrome with an early positive ELISA and a negative or evolving result on Western blot analysis. Unfortunately, there was not enough of each sample for us to perform Western blotting. The most liberal interpretation of these data is that 7 of the 563 patients (1.2 percent) who were tested for acute Epstein–Barr virus infection actually had primary HIV-1 infection. The other four patients listed in Table 1 as testing positive for HIV-1 RNA probably had chronic HIV-1 infection.

One limitation of this analysis is that we had no way to determine whether a patient was tested more than once, since all identifiers had been removed from the specimens. However, since the positive samples were obtained at widely separated times, it is likely that the four positive specimens and the three with results indicating possible acute infection were obtained from different patients. The number of viral copies detected may have been underestimated because we used serum samples rather than plasma.2

Given that about 1 percent of negative Epstein–Barr virus heterophil-antibody tests performed at our institution represent acute HIV-1 infection, we believe that health care providers who order such tests should perform an in-depth assessment of the patients' risk factors for HIV-1 and decide whether testing for acute HIV-1 infection is warranted.

Eric S. Rosenberg, M.D.
Angela M. Caliendo, M.D., Ph.D.
Bruce D. Walker, M.D.
Massachusetts General Hospital, Boston, MA 02114

2 References
  1. 1

    Schacker T, Collier AC, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-264[Erratum, Ann Intern Med 1997;126:174.]
    Web of Science | Medline

  2. 2

    Holodniy M, Mole L, Yen-Lieberman B, et al. Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol 1995;33:1562-1566
    Web of Science | Medline

Citing Articles (43)

Citing Articles

  1. 1

    Sabine Yerly, Bernard Hirschel. (2012) Diagnosing acute HIV infection. Expert Review of Anti-infective Therapy 10:1, 31-41
    CrossRef

  2. 2

    Andrew E. Petroll, Steven D. Pinkerton. (2011) A Conceptual Model of Interventions to Increase Diagnosis of Acute HIV Infection and Reduce Forward Transmission. AIDS and Behavior 15:8, 1715-1720
    CrossRef

  3. 3

    Kannan Ramar, Sean M Caples. (2011) Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiology 7:2, 241-249
    CrossRef

  4. 4

    Wesley H. Self. (2010) Acute HIV Infection: Diagnosis and Management in the Emergency Department. Emergency Medicine Clinics of North America 28:2, 381-392
    CrossRef

  5. 5

    Celia Serna-Bolea, Jose Muñoz, Jose M Almeida, Ariel Nhacolo, Emilio Letang, Tacilta Nhampossa, Eliana Ferreira, Pedro Alonso, Denise Naniche. (2010) High prevalence of symptomatic acute HIV infection in an outpatient ward in southern Mozambique: identification and follow-up. AIDS 24:4, 603-608
    CrossRef

  6. 6

    Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Rosenberg, Eric S., Cort, Alice M., Ebeling, Sally H.Peters, Christine C., Bell, Sigall K., Rosenberg, Eric S., . (2009) Case 11-2009. New England Journal of Medicine 360:15, 1540-1548
    Full Text

  7. 7

    Hasan Tezer, İlker Devrim, Ateş Kara, A. Bülent Cengiz, Gülten Seçmeer. (2008) Ganciclovir therapy in an immunocompetent child with resistant fever and hepatosplenomegaly due to cytomegalovirus infection. Who and when to treat?. International Journal of Infectious Diseases 12:3, 340-342
    CrossRef

  8. 8

    Rachel Smith, Nicola M Zetola, Jeffrey D Klausner. (2007) Beyond the end of exceptionalism: integrating HIV testing into routine medical care and HIV prevention. Expert Review of Anti-infective Therapy 5:4, 581-589
    CrossRef

  9. 9

    Nicola M. Zetola, Christopher D. Pilcher. (2007) Diagnosis and Management of Acute HIV Infection. Infectious Disease Clinics of North America 21:1, 19-48
    CrossRef

  10. 10

    Christopher D. Pilcher, Lisa Eaton, Seth Kalichman, Cláudia Bisol, Ricardo da Silva Souza. (2006) Approaching "HIV elimination": Interventions for acute HIV infection. Current HIV/AIDS Reports 3:4, 160-168
    CrossRef

  11. 11

    Emmanuel Bottieau, Jan Clerinx, Erwin Van den Enden, Marjan Van Esbroeck, Robert Colebunders, Alfons Van Gompel, Jef Van den Ende. (2006) Infectious Mononucleosis–Like Syndromes in Febrile Travelers Returning From the Tropics. Journal of Travel Medicine 13:4, 191-197
    CrossRef

  12. 12

    Jan Andersson. 2006. Clinical Features of Infectious Mononucleosis. , 99-124.
    CrossRef

  13. 13

    Toshio Naito, Nagako Kudo, Akihiro Inui, Naomi Matsumoto, Naoto Takeda, Hiroshi Isonuma, Takashi Dambara, Yasuo Hayashida. (2006) Causes of Infectious Mononucleosis-like Syndrome in Adult Patients. Internal Medicine 45:13, 833-834
    CrossRef

  14. 14

    Neda Sharghi, Ronald J Bosch, Kenneth Mayer, Max Essex, George R Seage. (2005) The Development and Utility of a Clinical Algorithm to Predict Early HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:4, 472-478
    CrossRef

  15. 15

    Pilcher, Christopher D., Fiscus, Susan A., Nguyen, Trang Q., Foust, Evelyn, Wolf, Leslie, Williams, Del, Ashby, Rhonda, O'Dowd, Judy Owen, McPherson, J. Todd, Stalzer, Brandt, Hightow, Lisa, Miller, William C., Eron, Joseph J. Jr., Cohen, Myron S., Leone, Peter A., . (2005) Detection of Acute Infections during HIV Testing in North Carolina. New England Journal of Medicine 352:18, 1873-1883
    Full Text

  16. 16

    E. Connick, S. MaWhinney, C. C. Wilson, T. B. Campbell. (2005) Challenges in the Study of Patients with HIV Type 1 Seroconversion. Clinical Infectious Diseases 40:9, 1355-1357
    CrossRef

  17. 17

    S. Melón, S. Méndez, B. Iglesias, J. A. Boga, M. Rodríguez, J. L. Fanjul, F. J. Méndez, M. Oña. (2005) Involvement of adenovirus in clinical mononucleosis-like syndromes in young children. European Journal of Clinical Microbiology & Infectious Diseases 24:5, 314-318
    CrossRef

  18. 18

    S. Kassutto, E. S. Rosenberg. (2004) Primary HIV Type 1 Infection. Clinical Infectious Diseases 38:10, 1447-1453
    CrossRef

  19. 19

    William C. Aird. (2004) Endothelium as an organ system. Critical Care Medicine 32:Supplement, S271-S279
    CrossRef

  20. 20

    Christopher D. Pilcher, Joseph J. Eron, Shannon Galvin, Cynthia Gay, Myron S. Cohen. (2004) Acute HIV revisited: new opportunities for treatment and prevention. Journal of Clinical Investigation 113:7, 937-945
    CrossRef

  21. 21

    Christopher D Pilcher, Matthew A Price, Irving F Hoffman, Shannon Galvin, Francis EA Martinson, Peter N Kazembe, Joseph J Eron, William C Miller, Susan A Fiscus, Myron S Cohen. (2004) Frequent detection of acute primary HIV infection in men in Malawi. AIDS 18:3, 517-524
    CrossRef

  22. 22

    J. M. Pincus, S. S. Crosby, E. Losina, E. R. King, C. LaBelle, K. A. Freedberg. (2003) Acute Human Immunodeficiency Virus Infection in Patients Presenting to an Urban Urgent Care Center. Clinical Infectious Diseases 37:12, 1699-1704
    CrossRef

  23. 23

    Martin Grünewald, Annelie Siegemund, Anja Grünewald, Anke Schmid, Mario Koksch, Christine Schöpflin, Stefanie Schauer, Martin Griesshammer. (2003) Plasmatic coagulation and fibrinolytic system alterations in PNH. Blood Coagulation & Fibrinolysis 14:7, 685-695
    CrossRef

  24. 24

    Kaeng W Lee, Gregory YH Lip. (2003) Acute coronary syndromes. Blood Coagulation & Fibrinolysis 14:7, 605-625
    CrossRef

  25. 25

    James Versalovic. (2003) Diagnostic Molecular Microbiology: Nucleic Acid Probes and Microbes. Pathology Case Reviews 8:4, 137-144
    CrossRef

  26. 26

    William C. Aird. (2003) Endothelial cell heterogeneity. Critical Care Medicine 31:Supplement, S221-S230
    CrossRef

  27. 27

    Offer Amir, Vinh D. Nguyen, Ben J. Barnett. (2003) Acute Human Immunodeficiency Virus Infection Presenting as Disseminated Gonococcal Infection. Southern Medical Journal 96:3, 284-286
    CrossRef

  28. 28

    Margarida Lima, Maria dos Anjos Teixeira, Maria L.uís Queirós, Ana Helena Santos, Cristina Gonçalves, J.oão Correia, F.átima Farinha, Fernanda Mendonça, José Manuel Neves Soares, J.úlia Almeida, Alberto Orfão, Benvindo Justiça. (2003) Immunophenotype and TCR-Vβ repertoire of peripheral blood T-cells in acute infectious mononucleosis. Blood Cells, Molecules, and Diseases 30:1, 1-12
    CrossRef

  29. 29

    Gordon R. Bernard. (2003) Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Critical Care Medicine 31:Supplement, S85-S93
    CrossRef

  30. 30

    Roberto Corti, Juan Jose Badimon. (2002) Biologic aspects of vulnerable plaque. Current Opinion in Cardiology 17:6, 616-625
    CrossRef

  31. 31

    Marcel Levi, Hugo ten Cate, Tom van der Poll. (2002) Endothelium: Interface between coagulation and inflammation. Critical Care Medicine 30:Supplement, S220-S224
    CrossRef

  32. 32

    William C. Aird. (2002) Endothelial cell dynamics and complexity theory. Critical Care Medicine 30:Supplement, S180-S185
    CrossRef

  33. 33

    Gordon R. Bernard, E. Wesley Ely, Theressa J. Wright, Joseph Fraiz, Jerome E. Stasek, James A. Russell, Irvin Mayers, Brian A. Rosenfeld, Peter E. Morris, S. Betty Yan, Jeffery D. Helterbrand. (2001) Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Critical Care Medicine 29:11, 2051-2059
    CrossRef

  34. 34

    Julian P.J. Halcox, Arshed A. Quyyumi. (2001) Coronary vascular endothelial function and myocardial ischemia: why should we worry about endothelial dysfunction?. Coronary Artery Disease 12:6, 475-484
    CrossRef

  35. 35

    Rochelle P. Walensky, Eric S. Rosenberg, Mary Jane Ferraro, Elena Losina, Bruce D. Walker, Kenneth A. Freedberg. (2001) Investigation of Primary Human Immunodeficiency Virus Infection in Patients Who Test Positive for Heterophile Antibody. Clinical Infectious Diseases 33:4, 570-572
    CrossRef

  36. 36

    Brian W. Grinnell, David Joyce. (2001) Recombinant human activated protein C: A system modulator of vascular function for treatment of severe sepsis. Critical Care Medicine 29, S53-S60
    CrossRef

  37. 37

    William C. Aird. (2001) Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis. Critical Care Medicine 29, S28-S34
    CrossRef

  38. 38

    Daniel E. Cohen, Bruce D. Walker. (2001) Human Immunodeficieny Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection. Clinical Infectious Diseases 32:12, 1756-1768
    CrossRef

  39. 39

    Irini Sereti, H. Clifford Lane. (2001) Immunopathogenesis of Human Immunodeficiency Virus: Implications for Immune‐Based Therapies. Clinical Infectious Diseases 32:12, 1738-1755
    CrossRef

  40. 40

    Sanjay M. Mehendale, Mary E. Shepherd, Ronald S. Brookmeyer, Richard D. Semba, Anand D. Divekar, Raman R. Gangakhedkar, Smita Joshi, Arun R. Risbud, Ramesh S. Paranjape, Deepak A. Gadkari, Robert C. Bollinger. (2001) Low Carotenoid Concentration and the Risk of HIV Seroconversion in Pune, India. Journal of Acquired Immune Deficiency Syndromes 26:4, 352-359
    CrossRef

  41. 41

    Sanjay M. Mehendale, Mary E. Shepherd, Ronald S. Brookmeyer, Richard D. Semba, Anand D. Divekar, Raman R. Gangakhedkar, Smita Joshi, Arun R. Risbud, Ramesh S. Paranjape, Deepak A. Gadkari, Robert C. Bollinger. (2001) Low Carotenoid Concentration and the Risk of HIV Seroconversion in Pune, India. JAIDS Journal of Acquired Immune Deficiency Syndromes 26:4, 352-359
    CrossRef

  42. 42

    George R. Dickens, Christopher J. Matheny, Peter E. Morris, G. Dennis Clifton, Mary H. H. Ensom. (1999) A Pilot Study of Estrogen’s Effects on Bronchial Myocyte Adhesion Molecule Expression. Pharmacotherapy 19:12, 1426-1431
    CrossRef

  43. 43

    Noel B. McDevitt. (1999) Deep Vein Thrombosis Prophylaxis. Plastic & Reconstructive Surgery 104:6, 1923-1928
    CrossRef